1.27
Health Sciences
Off-the-shelf immunotherapy can bring lymphoma patients closer to remission
Off-the-shelf immunotherapy can bring lymphoma patients closer to remission
A Penn study shows the promise of an off-the-shelf immunotherapy in relapse/refractory non-Hodgkin lymphoma, even when CAR T therapy fails.
This genetic variant is underdiagnosed, under-recognized, and deadly
This genetic variant is underdiagnosed, under-recognized, and deadly
A genetic variant which is found in about 3 percent of individuals of African ancestry is a more significant cause of heart failure than previously believed, according to a multi-institution study led by researchers at Penn Medicine.
Accelerating the creation of a wear-anywhere vest for COPD
Accelerating the creation of a wear-anywhere vest for COPD
Through the Penn Medicine Medical Device Accelerator, a physician’s back-of-a-napkin sketch may soon help patients breathe easier.
The new tool in fighting cancer: Antibiotics
The new tool in fighting cancer: Antibiotics
The antibiotic vancomycin alters the gut microbiome in a way that can help prime the immune system to more effectively attack tumor cells after radiation therapy.
‘Invisible,’ restricted horse racing therapy may leave a trail
‘Invisible,’ restricted horse racing therapy may leave a trail
Shockwave therapy is used in both horses and humans to speed healing, but it can also mask pain. For the first time, researchers led by Mary Robinson and Jinwen Chen have identified several biomarkers of the treatment, the use of which is restricted in horse racing.
The view from inside the ‘medical scandal’ of China’s gene-edited babies
The view from inside the ‘medical scandal’ of China’s gene-edited babies
In a Q&A, geneticist Kiran Musunuru describes his unintentional connection to the scientist behind the scandal and the book that came out of the experience.
Without metrics, how do you rate drug treatment facilities?
Without metrics, how do you rate drug treatment facilities?
With no national standard to measure drug treatment facilities, new research reveals opportunities to learn from patients to help create metrics.
These overlooked global diseases take a turn under the microscope
These overlooked global diseases take a turn under the microscope
Faculty at the School of Veterinary Medicine target neglected tropical diseases with advanced science, cross-disciplinary collaborations, and work in the lab and the field.
Living in poor communities, dying from heart disease
Living in poor communities, dying from heart disease
A new study, led by Penn Medicine, found counties that experienced the most economic distress from 2010 to 2015 had the highest cardiovascular mortality rates.
Researchers identify method to slow down cancer cells efforts to multiply
Researchers identify method to slow down cancer cells efforts to multiply
A study from the Abramson Cancer Center finds that turning on a key metabolic process could make soft tissue sarcoma more susceptible to treatment.
In the News
Science
Deciphering a cancer treatment’s dark side
Saar Gill of the Perelman School of Medicine said it would be easier to treat cancer using CAR-T cell therapy without the looming possibility of triggering cytokine release syndrome.
FULL STORY →
The New York Times
Can melatonin vapes safely help people sleep?
Julio Chirinos of the Perelman School of Medicine wrote an editorial to accompany a new study about the effects of marathon running on the heart. “Exercise is great for the entire body, including the arteries,” he said.
FULL STORY →
Rolling Stone
Can melatonin vapes safely help people sleep?
Philip Gehrman of the Perelman School of Medicine commented on the use of melatonin to aid sleep. “There have been quite a few randomized trials showing that melatonin is no better than placebo to help people sleep,” he said.
FULL STORY →
“Academic Minute” (WAMC, Northeast Public Radio)
Jonathan Moreno on bioethics and the transformation of health care in America
PIK Professor Jonathan Moreno discussed the book “Everybody Wants to Go to Heaven but Nobody Wants to Die: Bioethics and the Transformation of Health Care in America,” which he co-authored with President Amy Gutmann.
FULL STORY →
The New York Times
The F.D.A. is in trouble. Here’s how to fix it
Steven Joffe of the Perelman School of Medicine spoke about the tensions between groups that want medical products to be proven effective before the F.D.A. approves them for public use and groups that believe patients can make their own decisions once the products pass basic safety testing. “The F.D.A. has been moving in the latter direction under great political and public pressure,” he said.
FULL STORY →